share_log

騰盛博藥-B:翌日披露報表

BRII-B: Next Day Disclosure Return

HKEX ·  Sep 23, 2024 20:04

Summary by Moomoo AI

騰盛博藥生物科技有限公司於2024年9月23日提交了新的翌日披露報表,披露其已發行股份及庫存股份的變動。根據報表,公司於2024年9月19日至2024年9月23日期間,根據其2021年6月22日採納的股份獎勵計劃,向僱員及董事發行及配發新股。該股份獎勵計劃涉及的新股發行包括於9月20日發行10,291股,9月23日發行95,750股給僱員,以及同日發行285,375股給董事。這些股份的發行價格均為HKD 0。經過這些變動後,公司的已發行股份總數增至730,985,272股。公司確認,所有股份發行或庫存股份出售或轉讓均已獲董事會正式授權批准,並遵守所有適用的上市規則、法律及其他監管規定。
騰盛博藥生物科技有限公司於2024年9月23日提交了新的翌日披露報表,披露其已發行股份及庫存股份的變動。根據報表,公司於2024年9月19日至2024年9月23日期間,根據其2021年6月22日採納的股份獎勵計劃,向僱員及董事發行及配發新股。該股份獎勵計劃涉及的新股發行包括於9月20日發行10,291股,9月23日發行95,750股給僱員,以及同日發行285,375股給董事。這些股份的發行價格均為HKD 0。經過這些變動後,公司的已發行股份總數增至730,985,272股。公司確認,所有股份發行或庫存股份出售或轉讓均已獲董事會正式授權批准,並遵守所有適用的上市規則、法律及其他監管規定。
Tengshengbo Pharmaceutical Biological Technology Co., Ltd. submitted a new next-day disclosure report on September 23, 2024, disclosing the changes in the issued shares and treasury shares. According to the report, between September 19, 2024, and September 23, 2024, the company issued and distributed new shares to employees and directors based on its share incentive plan adopted on June 22, 2021. The new share issuances under the incentive plan included 10,291 shares issued on September 20 and 95,750 shares issued to employees, as well as 285,375 shares issued to directors on the same day. The issuance price for these shares was all HKD 0. After these changes, the total number of issued shares of the company increased to 730,985,272 shares. The company confirmed that all share issuances or treasury share sales or transfers have been formally authorized and approved by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements.
Tengshengbo Pharmaceutical Biological Technology Co., Ltd. submitted a new next-day disclosure report on September 23, 2024, disclosing the changes in the issued shares and treasury shares. According to the report, between September 19, 2024, and September 23, 2024, the company issued and distributed new shares to employees and directors based on its share incentive plan adopted on June 22, 2021. The new share issuances under the incentive plan included 10,291 shares issued on September 20 and 95,750 shares issued to employees, as well as 285,375 shares issued to directors on the same day. The issuance price for these shares was all HKD 0. After these changes, the total number of issued shares of the company increased to 730,985,272 shares. The company confirmed that all share issuances or treasury share sales or transfers have been formally authorized and approved by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more